Success Metrics

Clinical Success Rate

62.1%

Based on 18 completed trials

Completion Rate

62%(18/29)

Active Trials

13(24%)

Results Posted

61%(11 trials)

Terminated

11(20%)

Phase Distribution

Ph not_applicable

22%

Ph early_phase_1

Ph phase_1

15%

Ph phase_2

Ph phase_3

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution27 total trials

Early Phase 1First-in-human

2(7.4%)

Phase 1Safety & dosage

8(29.6%)

Phase 2Efficacy & side effects

3(11.1%)

Phase 3Large-scale testing

1(3.7%)

Phase 4Post-market surveillance

1(3.7%)

N/ANon-phased studies

12(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

51.4%

18 of 35 finished

Non-Completion Rate

48.6%

17 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(14)

Completed(18)

Terminated(17)

Other(5)

Detailed Status

Completed18

Terminated11

Recruiting8

Withdrawn6

Active, not recruiting5

unknown4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

62.1%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (7.4%)

Phase 18 (29.6%)

Phase 23 (11.1%)

Phase 31 (3.7%)

Phase 41 (3.7%)

N/A12 (44.4%)

Trials by Status

not_yet_recruiting12%

recruiting815%

withdrawn611%

active_not_recruiting59%

terminated1120%

unknown47%

completed1833%

suspended12%

Recent Activity

13 active trials

Showing 5 of 54

terminatedearly_phase_1

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

NCT04037527

View all 54 trials

Clinical Trials (54)

Showing 20 of 54 trialsScroll for more

NCT05204290Early Phase 1

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

Terminated

NCT05692635Phase 2

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Recruiting

NCT05595577Not Applicable

Improving Exercise Capacity With a Tailored Physical Activity Intervention

Recruiting

NCT03987555

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Suspended

NCT04037527Phase 1

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Terminated

NCT06717334

A Study of Lung Cancer Screening in People With Unexplained Weight Loss

Recruiting

NCT03420118Not Applicable

Study of Biomarkers in Gynecological Cancers

Recruiting

NCT01991379Phase 1

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Active Not Recruiting

NCT03432806

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Active Not Recruiting

NCT03133208

Sepsis Associated Encephalopathy (SAE) Biomarkers

Active Not Recruiting

NCT05091190Not Applicable

Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers

Active Not Recruiting

NCT07122206

Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

Not Yet Recruiting

NCT02995252

The HOPE Study: Characterizing Patients With Hepatitis B and C

Recruiting

NCT06424652Not Applicable

Effect of Physiologic Insulin Administration on Cognition

Completed

NCT02348749Phase 1

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Completed

NCT01186367Not Applicable

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer

Completed

NCT04273893Not Applicable

Lymphocyte Depletion and Change in Lymphocyte Functionality

Active Not Recruiting

NCT03259230

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Completed

NCT05854966Phase 2

CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Withdrawn

NCT06058182

RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome

Recruiting

Drug Details

Intervention Type: PROCEDURE
Total Trials: 54